Stay updated on IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial
Sign up to get notified when there's something new on the IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial page.

Latest updates to the IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial page
- Check2 days agoChange DetectedA newer revision tag (v3.5.5) was added to the page history and the previous tag (v3.5.4) was removed. This reflects an updated page version in the study record history.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision: v3.5.4 was added as the latest entry in the history, replacing Revision: v3.5.3. This documents an update to the record version rather than content changes to the study data.SummaryDifference0.1%

- Check45 days agoChange DetectedUpdates the page’s displayed software/version identifier from the previous revision to the current one.SummaryDifference0.1%

- Check52 days agoChange DetectedA new site revision v3.5.2 was added and the previous revision v3.5.0 was removed from the history.SummaryDifference0.1%

- Check81 days agoChange DetectedAdded revision: v3.5.0 and removed revision: v3.4.3 from the record history.SummaryDifference0.1%

- Check95 days agoChange DetectedNew revision entry v3.4.3 added to the history and the v3.4.2 entry removed.SummaryDifference0.1%

Stay in the know with updates to IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial page.